Naveen Pemmaraju: Always wonderful to catch up and discuss the future of the Myeloproliferative Neoplasms research field!

Naveen Pemmaraju recently shared a post on LinkedIn:

“Always wonderful to catch up with our great friend, world expert and Myeloproliferative Neoplasms (MPN) guru Professor Ruben Mesa! We had the splendid opportunity to catch up at the 2nd annual Myeloid Malignancies Workshop in New York City at Mt Sinai Hospital earlier this month and we got to discuss many new ideas together for the future of the MPN research field!”

Source: Naveen Pemmaraju/LinkedIn

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML. He has been named MDACC’s, Department of Leukemia, Inaugural Director of BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.